Federal Court reinstates decision that REMICADE new use patent is valid and infringed

Published date24 February 2021
Subject MatterPatents,Appeals,Obviousness,Prior Art,Biosimilars,Patent Litigation,Pharmaceutical Patents,Patent Infringement,Patent Validity,Anticipation
AuthorUrszula Wojtyra,Katie Lee
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT